These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

320 related articles for article (PubMed ID: 38186312)

  • 1. Functional role of translocator protein and its ligands in ocular diseases (Review).
    Yu M; Zhao S
    Mol Med Rep; 2024 Feb; 29(2):. PubMed ID: 38186312
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential effects of TSPO ligands on mitochondrial function in mouse microglia cells.
    Bader S; Wolf L; Milenkovic VM; Gruber M; Nothdurfter C; Rupprecht R; Wetzel CH
    Psychoneuroendocrinology; 2019 Aug; 106():65-76. PubMed ID: 30954920
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Translocator protein (18 kDa) (Tspo) in the retina and implications for ocular diseases.
    Hector M; Langmann T; Wolf A
    Prog Retin Eye Res; 2024 May; 100():101249. PubMed ID: 38430990
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Translocator protein (18 kDa) (TSPO) is expressed in reactive retinal microglia and modulates microglial inflammation and phagocytosis.
    Karlstetter M; Nothdurfter C; Aslanidis A; Moeller K; Horn F; Scholz R; Neumann H; Weber BH; Rupprecht R; Langmann T
    J Neuroinflammation; 2014 Jan; 11():3. PubMed ID: 24397957
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Translocator protein (18 kDa) (TSPO) ligands activate Nrf2 signaling and attenuate inflammatory responses and oxidative stress in human retinal pigment epithelial cells.
    Rashid K; Verhoyen M; Taiwo M; Langmann T
    Biochem Biophys Res Commun; 2020 Jul; 528(2):261-268. PubMed ID: 32482385
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chronic administration of XBD173 ameliorates cognitive deficits and neuropathology via 18 kDa translocator protein (TSPO) in a mouse model of Alzheimer's disease.
    Pradhan AK; Neumüller T; Klug C; Fuchs S; Schlegel M; Ballmann M; Tartler KJ; Pianos A; Garcia MS; Liere P; Schumacher M; Kreuzer M; Rupprecht R; Rammes G
    Transl Psychiatry; 2023 Oct; 13(1):332. PubMed ID: 37891168
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TSPO Ligands Boost Mitochondrial Function and Pregnenolone Synthesis.
    Lejri I; Grimm A; Hallé F; Abarghaz M; Klein C; Maitre M; Schmitt M; Bourguignon JJ; Mensah-Nyagan AG; Bihel F; Eckert A
    J Alzheimers Dis; 2019; 72(4):1045-1058. PubMed ID: 31256132
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structural requirements to obtain highly potent and selective 18 kDa Translocator Protein (TSPO) Ligands.
    Taliani S; Pugliesi I; Da Settimo F
    Curr Top Med Chem; 2011; 11(7):860-86. PubMed ID: 21291396
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Channel-like functions of the 18-kDa translocator protein (TSPO): regulation of apoptosis and steroidogenesis as part of the host-defense response.
    Veenman L; Papadopoulos V; Gavish M
    Curr Pharm Des; 2007; 13(23):2385-405. PubMed ID: 17692008
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The translocator protein (18kDa) and its role in neuropsychiatric disorders.
    Barichello T; Simões LR; Collodel A; Giridharan VV; Dal-Pizzol F; Macedo D; Quevedo J
    Neurosci Biobehav Rev; 2017 Dec; 83():183-199. PubMed ID: 29054730
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of 18 kDa mitochondrial translocator protein (TSPO) in programmed cell death, and effects of steroids on TSPO expression.
    Veenman L; Gavish M
    Curr Mol Med; 2012 May; 12(4):398-412. PubMed ID: 22348610
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Translocator protein (18 kDa) as a pharmacological target in adipocytes to regulate glucose homeostasis.
    Li J; Papadopoulos V
    Biochem Pharmacol; 2015 Sep; 97(1):99-110. PubMed ID: 26123521
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mitochondria modulatory effects of new TSPO ligands in a cellular model of tauopathies.
    Grimm A; Lejri I; Hallé F; Schmitt M; Götz J; Bihel F; Eckert A
    J Neuroendocrinol; 2020 Jan; 32(1):e12796. PubMed ID: 31536662
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protein-ligand and membrane-ligand interactions in pharmacology: the case of the translocator protein (TSPO).
    Hatty CR; Banati RB
    Pharmacol Res; 2015 Oct; 100():58-63. PubMed ID: 26238176
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Ligands of Translocator Protein: Design and Biological Properties.
    Mokrov GV; Deeva OA; Gudasheva TA
    Curr Pharm Des; 2021; 27(2):217-237. PubMed ID: 32881658
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting mitochondrial energy metabolism with TSPO ligands.
    Gut P
    Biochem Soc Trans; 2015 Aug; 43(4):537-42. PubMed ID: 26551690
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An update into the medicinal chemistry of translocator protein (TSPO) ligands.
    Barresi E; Robello M; Costa B; Da Pozzo E; Baglini E; Salerno S; Da Settimo F; Martini C; Taliani S
    Eur J Med Chem; 2021 Jan; 209():112924. PubMed ID: 33081988
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Translocator protein as a promising target for novel anxiolytics.
    Costa B; Da Pozzo E; Martini C
    Curr Top Med Chem; 2012; 12(4):270-85. PubMed ID: 22204481
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Translocator protein (18 kDa) (TSPO) as a therapeutic target for anxiety and neurologic disorders.
    Nothdurfter C; Baghai TC; Schüle C; Rupprecht R
    Eur Arch Psychiatry Clin Neurosci; 2012 Nov; 262 Suppl 2():S107-12. PubMed ID: 22923187
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Translocator protein (18 kDa) (TSPO) as a therapeutic target for neurological and psychiatric disorders.
    Rupprecht R; Papadopoulos V; Rammes G; Baghai TC; Fan J; Akula N; Groyer G; Adams D; Schumacher M
    Nat Rev Drug Discov; 2010 Dec; 9(12):971-88. PubMed ID: 21119734
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.